#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine neuroendocrine tumour Anal squamous cell carcinoma Immunodeficiency common variable Haemophilia A without inhibitors T-cell type acute leukaemia Raynaud's phenomenon Rectal cancer Follicular lymphoma Congenital megacolon Leukoencephalopathy Small for dates baby Bronchiectasis Autoinflammation with infantile enterocolitis Congenital cystic kidney disease Chondrodystrophy More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Trials in Disease Nephrotic syndrome – Diagnostics Primary mediastinal large B-cell lymphoma Synovial sarcoma – Trials in Disease Hepatic angiosarcoma Retinoblastoma – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Erdheim-Chester disease – Diagnostics Hereditary hypophosphataemic rickets – Basic Information Brain stem glioma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    OXYBUTYNIN HYDROCHLORIDE Specific Nucleic Acid Sna-Xfsc Mva-209-Fsp-B3 Enoxaparin Sodium Gs-5245 ACICLOVIR SODIUM Cefuroxime Mometasone Furoate Ph. Eur. Prednisone Triglycerides, Medium Chain ARI0008 Indacaterol Maleate Esk-001 PRT3789 BRENSOCATIB Resatorvid Sym025 Omo-103 Elivaldogene Autotemcel IHMA-2121771-2 More therapies…

    Learn about Your Condition

    Systemic scleroderma Insomnia Lip and/or oral cavity cancer Renal cancer Organ donor Post-traumatic stress disorder Colon cancer stage II Vascular graft thrombosis Pain in extremity Astrocytoma malignant Acute myeloid leukaemia Sarcoma metastatic Metabolic disorder Pancreatitis acute Osteogenesis imperfecta More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Investigative Techniques

  • Study on Managing Rheumatological Side Effects in Cancer Patients Using Fludeoxyglucose (18F) and Checkpoint Inhibitors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    • Relatlimab
    • Ipilimumab
    The Netherlands

  • Study on Dopaminergic Pathway Disruption in Comatose Patients with Traumatic Brain Injury Using [18F]LBT-999

    Recruiting

    4 1 1
    Investigated Diseases:
    • Craniocerebral injury
    France

  • Study on Early Detection of Liver Cancer Using Hyperpolarized Pyruvate MRI for Patients with Primary Liver Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study on Amiodarone Hydrochloride for Treating Atrial Fibrillation in Critically Ill Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Amiodarone Hydrochloride
    Denmark

  • Study Comparing Gallium (68Ga) Gozetotide and Zirconium (89Zr) Girentuximab PET Scans for Detecting Tumors in Patients with Metastatic Renal Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Gallium (68Ga) Gozetotide
    • ZIRCONIUM (89ZR) GIRENTUXIMAB
    • Gozetotide
    The Netherlands

  • Study Comparing [68Ga]Ga-PentixaFor PET/CT and AVS for Diagnosing Primary Aldosteronism in Patients with Hypertension

    Recruiting

    4 1 1
    Investigated Diseases:
    • Primary hyperaldosteronism
    Investigated Drugs:
    • Pentixafor
    • Gallium (68Ga)
    The Netherlands
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!